Repliform^® Tissue Regeneration Matrix

Product Information

• Human dermis architecture is a highly complex structure of banded collagen fibers, elastin, proteoglycans and vascular plexus that provides tensile strength, volume, elasticity and durability
• A patented process designed to remove cells that are likely targets of the body's immune response
• Collagen fibers are banded in omni-directional patterns to provide tensile strength, including resistance to suture pull-through
• Human dermis is pliable allowing it to conform to irregular surfaces

Device Illustration

Reimbursement (Physician & Facility)

• Click here to view all Gynecology coding & reimbursement content.

Additional Information

Repliform Tissue Regeneration Matrix is regulated by the FDA as human tissue for transplantation and is exclusively distributed in the USA by Boston Scientific Corporation. All tissue processing and the supplying tissue banks comply with the requirements of the CFR regulation for the procurement and processing of banked human tissues (CFR Title 21, Part 1270 & 1271) and methodologies of the American Association of Tissue Banks.

This product is processed by LifeCell Corporation, an accredited member of the American Association of Tissue Banks. Donors are screened by medical records, social history, and serological testing.

Repliform is a trademark of LifeCell Corporation.